Zhejiang Tailin BioEngineering Co.,Ltd (SHE:300813)

SHE:300813 Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Operating Revenue	284.97	314.25	236.32	345	253.64	175.5
Other Revenue	34.75	34.75	33.54	28.88	29.61	24.73
Revenue	319.72	349	269.86	373.88	283.25	200.24
Revenue Growth (YoY)	3.40%	29.33%	-27.82%	32.00%	41.46%	10.67%
Cost of Revenue	169.81	197.86	142	180.31	111.82	77.04
Gross Profit	149.91	151.14	127.86	193.57	171.43	123.2
Selling, General & Admin	81.4	78.17	70.72	73.22	61	52.14
Research & Development	62.01	62.34	58.4	64.47	55.05	37.72
Other Operating Expenses	1.08	-2.85	-5.22	-6.87	-4.32	-4.46
Operating Expenses	147.19	139.33	125.09	129.8	113.61	85.11
Operating Income	2.72	11.81	2.77	63.78	57.82	38.09
Interest Expense	-3.23	-14.78	-0.59	-0.88	-0.13	-
Interest & Investment Income	10.1	11.59	11.11	10.27	9.2	6.85
Currency Exchange Gain (Loss)	0.14	0.14	0.3	-0.06	-0.02	-0.17
Other Non Operating Income (Expenses)	0.02	-0.13	-0.04	-0.02	-0.03	-1.18
EBT Excluding Unusual Items	9.74	8.63	13.56	73.09	66.84	43.58
Gain (Loss) on Sale of Investments	0	-	-0.01	-	0.05	-
Gain (Loss) on Sale of Assets	-0.37	-	-0	0.02	-	-0.01
Asset Writedown	-0.12	-0.55	-0.08	-0.03	-0.16	-0.01
Other Unusual Items	6	4.68	8.51	6.86	2.91	8.17
Pretax Income	15.25	12.77	21.98	79.95	69.64	51.73
Income Tax Expense	-0.93	0.51	3.53	0.26	6.11	3.34
Earnings From Continuing Operations	16.18	12.25	18.45	79.69	63.53	48.39
Minority Interest in Earnings	0.28	0.8	1.22	-	-	-
Net Income	16.46	13.05	19.67	79.69	63.53	48.39
Net Income to Common	16.46	13.05	19.67	79.69	63.53	48.39
Net Income Growth	70.18%	-33.65%	-75.32%	25.43%	31.30%	40.63%
Shares Outstanding (Basic)	116	109	109	108	109	106
Shares Outstanding (Diluted)	124	109	116	112	109	106
Shares Change (YoY)	6.74%	-6.00%	3.09%	3.28%	2.57%	30.28%
EPS (Basic)	0.14	0.12	0.18	0.74	0.58	0.46
EPS (Diluted)	0.13	0.12	0.17	0.71	0.58	0.46
EPS Growth	59.44%	-29.41%	-76.06%	21.45%	28.01%	7.94%
Free Cash Flow	38.8	6.12	-174.31	60.24	10.05	99.21
Free Cash Flow Per Share	0.31	0.06	-1.51	0.54	0.09	0.94
Dividend Per Share	0.100	0.100	0.100	0.231	0.144	0.096
Dividend Growth	-	-	-56.67%	59.95%	50.00%	-66.66%
Gross Margin	46.89%	43.31%	47.38%	51.77%	60.52%	61.52%
Operating Margin	0.85%	3.38%	1.03%	17.06%	20.41%	19.02%
Profit Margin	5.15%	3.74%	7.29%	21.31%	22.43%	24.16%
Free Cash Flow Margin	12.14%	1.75%	-64.59%	16.11%	3.55%	49.55%
EBITDA	22.96	28.17	13.96	72.88	64.47	46.4
EBITDA Margin	7.18%	8.07%	5.17%	19.49%	22.76%	23.17%
D&A For EBITDA	20.24	16.36	11.19	9.1	6.65	8.31
EBIT	2.72	11.81	2.77	63.78	57.82	38.09
EBIT Margin	0.85%	3.38%	1.03%	17.06%	20.41%	19.02%
Effective Tax Rate	-	4.02%	16.07%	0.33%	8.78%	6.46%
Revenue as Reported	319.72	349	269.86	373.88	283.25	200.24
Advertising Expenses	-	1.66	2.19	2.44	2.94	0.12

Source: S&P Global Market Intelligence. Standard template. Financial Sources.